---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-22-002917"
form_type: "8-K"
ticker: "NAII"
cik: "0000787253"
company_name: "NATURAL ALTERNATIVES INTERNATIONAL INC"
filed_at: "2022-02-10T23:59:59+00:00"
generated_at: "2026-06-27T09:23:40.464109+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# NAI Q2 FY2022 net sales down 21.5% YoY to $37.7M; diluted EPS $0.30 vs $0.57

## Summary
- Net income $1.8M ($0.30 diluted EPS) vs $3.6M ($0.57) in prior-year quarter; private-label sales fell 25.7% to $33.7M.
- Sales to largest customer dropped 48%; CarnoSyn beta-alanine revenue up 46.9% to $4.1M; backlog exceeded $12M due to supply chain issues.
- FY2022 guidance: net sales flat to slightly up vs FY2021; H2 net sales expected to increase 10%-13% YoY; operating margin 8%-11%.
- Cash and equivalents $19.4M; $20.0M available under credit line; new blending capacity online in Vista, CA.

## SEC filing metadata
- accession: 0001437749-22-002917
- form_type: 8-K
- ticker: NAII
- cik: 0000787253
- company_name: NATURAL ALTERNATIVES INTERNATIONAL INC
- filed_at: 2022-02-10T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/787253/000143774922002917/0001437749-22-002917-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/787253/000143774922002917/naii20220209_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-22-002917
- JSON: https://secwatch.observer/filing/0001437749-22-002917.json
- Plain text: https://secwatch.observer/filing/0001437749-22-002917.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.